Union: Sanofi poised for restructuring

Sanofi-Aventis is prepping for a "major restructuring" of some of its business, trade union officials told Reuters. The French drugmaker is expected to release more details at another union meeting next week. Company officials declined to comment. Report

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.